Soligenix, Inc. (SNGX): Price and Financial Metrics

Soligenix, Inc. (SNGX): $4.24

0.42 (+10.99%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

SNGX Price/Volume Stats

Current price $4.24 52-week high $32.00
Prev. close $3.82 52-week low $3.30
Day low $3.81 Volume 87,500
Day high $4.28 Avg. volume 142,219
50-day MA $5.88 Dividend yield N/A
200-day MA $8.70 Market Cap 4.18M

SNGX Stock Price Chart Interactive Chart >


Soligenix, Inc. (SNGX) Company Bio


Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.


SNGX Latest News Stream


Event/Time News Detail
Loading, please wait...

SNGX Latest Social Stream


Loading social stream, please wait...

View Full SNGX Social Stream

Latest SNGX News From Around the Web

Below are the latest news stories about SOLIGENIX INC that investors may wish to consider to help them evaluate SNGX as an investment opportunity.

Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fair

Key Insights Soligenix will host its Annual General Meeting on 15th of December Total pay for CEO Christopher Schaber...

Yahoo | December 9, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning!

William White on InvestorPlace | December 1, 2023

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that an article describing the potential use of HyBryte™ in the treatment of cutaneous T-cell lymphoma (CTCL) has been published in Frontiers in Drug Discovery. The mini-review summarizes findings about the use, mechanism and effectiveness of HyBryte™ in the treatment of CT

Yahoo | December 1, 2023

Jefferies Is Pounding the Table on Snap (SNAP) Stock

Snap stock is heading higher on Thursday after the social media company's shares were upgraded to a 'buy' rating by Jefferies analysts.

William White on InvestorPlace | November 30, 2023

TSLA Stock Alert: The Tesla Cybertruck Launches Today

Tesla stock is on the move Thursday as investors in TSLA shares prepare for the official Cybertruck launch event taking place today!

William White on InvestorPlace | November 30, 2023

Read More 'SNGX' Stories Here

SNGX Price Returns

1-mo -30.97%
3-mo -58.59%
6-mo -57.18%
1-year -60.45%
3-year -98.42%
5-year -97.51%
YTD -65.00%
2023 -88.83%
2022 -31.55%
2021 -48.41%
2020 -11.72%
2019 68.60%

Continue Researching SNGX

Want to see what other sources are saying about Soligenix Inc's financials and stock price? Try the links below:

Soligenix Inc (SNGX) Stock Price | Nasdaq
Soligenix Inc (SNGX) Stock Quote, History and News - Yahoo Finance
Soligenix Inc (SNGX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!